Does This Side Effect Spell Doom for the GLP-1s?

σε πρόσθεσε στο Εκπαίδευση

2025-08-19 06:28:42 - Μετάφραση -

GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro have taken the world by storm. Initially approved for type 2 diabetes, they quickly became household names for their impressive weight-loss effects. Backed by celebrity endorsements and millions of success stories, these medications promised not just slimmer bodies, but longer, healthier lives. But a growing number of adverse event...

0 Σχόλια 0 Μοιράστηκε 2χλμ. Views 0 Προεπισκόπηση